MedChem Campus 2023
The Tübingen Center for Academic Drug Discovery (TüCAD2), established in 2012, is hosting a one-day event that underscores its commitment to the pharmacological validation of genetically identified targets. With a history of bringing four compounds to human trials, this event will spotlight case studies from drug discovery experts representing institutions like ANOVA, Bayer, and UCLA. Aimed at young professionals in drug discovery, medicinal chemistry, and postdocs, TüCAD2 has enriched the academic community since 2019 with teachings in medchem, preclinical development, and fundraising. We are thrilled to participate and eager to share insights into our unique services and capabilities.